
Active Capital takes majority stake in Arnold Suhr
Amsterdam-based GP Active Capital Company has taken a majority stake in speciality chemicals business Arnold Suhr.
The deal saw the GP acquire a 70% stake in Arnold Suhr, while commercial director Kasper Bouwman took a 20% stake and director Nico La Maitre secured 10%.
Active Capital's investment should enable the group to keep expanding, with plans to open a US office and to invest in more factories in Madagascar, where it already has operations.
In recent times, Arnold Suhr has tried to refocus its offering and to become more specialised on a smaller section of the market, having cut its product range from 360 to 60.
The company, which will continue to invest in additional production plants in new locations, recently made its first steps in Guatemala, where it acquired a site for the cultivation of sugar substitute stevia (used in food products and soft drinks) through a local joint venture.
Active Capital recently acquired a majority stake in wet wipes manufacturer Codi Group from Value Enhancement partners, which had owned the group since 2013. The investment came shortly after Active Capital closed its third buyout fund with €45m in commitments – a step up from its predecessor, which had a €30m target. The fund focuses on companies with revenues of €10-80m.
Company
Established in 1947, Arnold Suhr is a speciality chemicals company providing ingredients for the food and beverages, pharmaceuticals, healthcare, and chemicals sectors. Ingredients include quinine, the sweetener stevia, and iodine. Its customers include large multinational groups including Schweppes and the Coca-Cola Company.
Based in Hilversum, the Netherlands, the group also has operations in China and Madagascar. Its turnover currently amounts to around €40m for a €1-2m EBITDA.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater